KZA 0.00% 8.0¢ kazia therapeutics limited

Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics, page-2

  1. 2,071 Posts.
    lightbulb Created with Sketch. 443
    R&P- Excellent find. The next word from Brastianos' Alliance trial, I think it's NCT03994796, is worth waiting for.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.